# Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy

> **NCT00653848** · PHASE3 · UNKNOWN · sponsor: **Scandinavian Prostate Cancer Group** · enrollment: 378 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00653848
- **Lead sponsor:** Scandinavian Prostate Cancer Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-05
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 378 (ACTUAL)
- **Last updated:** 2021-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653848, "Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00653848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*